CNBC interviews Edward M. Ellison, MD, about remdesivir, pandemic’s impact on physicians
In a wide-ranging interview Friday with CNBC about COVID-19, Edward M. Ellison, MD, executive medical director and chairman of Southern California Permanente Medical Group, characterized the remdesivir clinical trial as “encouraging.”